Follow
Viet Do
Viet Do
Liverpool Cancer Therapy Centre Radiation Oncology
Verified email at health.nsw.gov.au
Title
Cited by
Cited by
Year
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre …
SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ...
The lancet oncology 19 (3), 295-309, 2018
5542018
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a …
SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ...
Lancet oncology, 2019
3762019
The effect of waiting for radiotherapy for grade III/IV gliomas
V Do, V Gebski, MB Barton
Radiotherapy and Oncology 57 (2), 131-136, 2000
1762000
Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy?
M Lock, E Chow, GR Pond, V Do, C Danjoux, R Dinniwell, J Lea, A Bezjak
Clinical Oncology 16 (5), 332-338, 2004
482004
Maintaining bone health in patients with prostate cancer
DJ Holmes‐Walker, H Woo, H Gurney, VT Do, DR Chipps
Medical journal of Australia 184 (4), 176-179, 2006
412006
Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy?
AH Brand, V Do, A Stenlake
International Journal of Gynecologic Cancer 22 (5), 2012
332012
Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma
R Choo, V Do, S Herschorn, G DeBoer, C Danjoux, G Morton, CH Cheng, ...
International Journal of Radiation Oncology* Biology* Physics 53 (2), 290-296, 2002
332002
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial
CCB Post, SM de Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ...
International Journal of Radiation Oncology Biology physics, 2020
32*2020
Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose–volume histogram parameter reproducibility and anatomic position stability
E Flower, V Do, J Sykes, C Dempsey, L Holloway, K Summerhayes, ...
Brachytherapy 16 (2), 387-392, 2017
292017
The role of serial free/total prostate‐specific antigen ratios in a watchful observation protocol for men with localized prostate cancer
V Do, R Choo, G De Boer, L Klotz, C Danjoux, G Morton, E Szumacher, ...
BJU international 89 (7), 703-709, 2002
222002
Urodynamic findings 3 months after radiotherapy in patients treated with conformal external beam radiotherapy for prostate carcinoma
V Do, R Choo, G Deboer, S Herschorn, C Danjoux, CH Chen, I Barak
BJU international 90 (1), 62-67, 2002
212002
Uterine papillary serous carcinoma: patterns of failure and survival
W Wang, V Do, R Hogg, G Wain, A Brand, C Bull, A Stenlake, V Gebski
Australian and New Zealand Journal of Obstetrics and Gynaecology 49 (4), 419-425, 2009
162009
Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancer.
R Choo, V Do, L Sugar, L Klotz, E Bahk, E Hong, C Danjoux, G Morton, ...
The Canadian Journal of Urology 11 (1), 2118-2124, 2004
142004
A nurse- and peer-led psycho-educational intervention to support women with gynaecological cancers receiving curative radiotherapy: The PeNTAGOn randomised controlled trial …
P Schofield, K Gough, M Pascoe, R Bergin, K White, L Mileshkin, ...
Gynecologic Oncology, 2020
132020
Non–prostate-specific membrane antigen-avid metastatic lung nodule from primary prostatic adenocarcinoma
D Shetty, H Loh, C Bui, R Mansberg, A Hadjashrafi, V Do
Clinical Nuclear Medicine 41 (10), 776-778, 2016
132016
Estimation of an optimal chemotherapy utilisation rate for cancer: setting an evidence-based benchmark for quality cancer care
SA Jacob, WL Ng, V Do
Clinical Oncology 27 (2), 77-82, 2015
132015
A nurse- and peer-led psycho-educational intervention to support women with gynaecological cancers receiving curative radiotherapy: The PeNTAGOn randomised controlled trial …
IJ P.Schofield,K.Gough, M.Pascoe, R.Bergin, K.White, L.Mileshkin, D.Bernshaw ...
13*
Radiation therapy techniques and treatment-related toxicity in the PORTEC-3 trial: Comparison of 3-dimensional conformal radiation therapy versus intensity-modulated radiation …
BG Wortman, CCB Post, ME Powell, P Khaw, A Fyles, R D'Amico, ...
International Journal of Radiation Oncology* Biology* Physics 112 (2), 390-399, 2022
112022
Results of the Australasian (Trans‐Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC‐3 trial
MG Jameson, J McNamara, M Bailey, PE Metcalfe, LC Holloway, K Foo, ...
Journal of Medical Imaging and Radiation Oncology 60 (4), 554-559, 2016
92016
Postoperative concurrent chronomodulated 5-fluorouracil/leucovorin infusion and pelvic radiotherapy for squamous cell carcinoma of the ovary arising from mature cystic teratoma
VT Do, GM Thomas, GA Bjarnason
International Journal of Gynecologic Cancer 11 (5), 2001
92001
The system can't perform the operation now. Try again later.
Articles 1–20